卵巣癌 大韓民国 の治療 — 費用 2026

Samsung Medical Center and Asan Medical Center are top-rated hospitals for ovarian cancer treatment in South Korea. These institutions hold JCI and ISO certifications and rank among the world's best for oncology. They offer advanced therapies like HIPEC, proton therapy, and robotic surgery.

• Samsung Medical Center: Ranked 3rd globally for oncology by Newsweek for advanced cancer care.
• Asan Medical Center: Performs the highest volume of gynecologic surgeries in South Korea annually.
• Seoul National University: Known for research-driven protocols and specialized fertility-sparing options for patients.
• Severance Hospital: JCI-accredited facility offering specialized international patient services and HIPEC expertise.

Bookimed Expert Insight: Korea University Anam Hospital offers a distinct advantage for patients concerned about surgical scarring. While many centers use the Da Vinci system, this hospital pioneered robotic techniques that reduce scar size by 90%. Their bloodless surgery protocols also contribute to faster recovery and lower infection risks for complex oncology cases.

Patient Consensus: Patients note that major Seoul hospitals offer significant savings compared to US treatment. They emphasize choosing a specific surgeon experienced in your cancer stage rather than just the hospital name.

South Korea offers ultra-modern ovarian cancer treatments including robotic-assisted debulking surgery and Hyperthermic Intraperitoneal Chemotherapy. Leading Seoul centers integrate genomic profiling to prescribe targeted PARP inhibitors and heavy ion therapy. Specialized oncology teams utilize the Da Vinci system to improve precision and accelerate recovery.

• Robotic surgery: Da Vinci systems allow precise tumor removal through minimal incisions.
• HIPEC protocol: Heated chemotherapy is applied during surgery to eliminate microscopic cancer cells.
• Heavy ion therapy: Carbon ion beams treat resistant tumors at Severance Hospital center.
• Targeted therapy: PARP inhibitors like Olaparib treat BRCA-positive cases following genetic testing.
• Immunotherapy trials: Major academic hospitals provide access to CAR-T and checkpoint inhibitor trials.

Bookimed Expert Insight: South Korea is a global leader in surgical technology, with Severance Hospital alone hosting over 2,000 specialist doctors. While many countries focus solely on chemotherapy, Korean centers like Korea University Anam Hospital pioneered robotic reconstructions. This heavy emphasis on robotic precision often results in significantly shorter hospital stays than traditional open-abdominal surgeries.

Patient Consensus: Patients emphasize the importance of early genetic testing in Korea to qualify for advanced clinical trials and PARP inhibitors. Many note that robotic debulking allowed them to return to work within four weeks and suggest using coordinators for English support.

South Korea reports a 65.9% overall 5-year relative survival rate for ovarian cancer. Localized cases show high success with survival reaching 92.5%. Advanced treatments including HIPEC and robotic surgery contribute to these outcomes. Most procedures are performed at JCI-accredited tertiary centers in Seoul.

• Localized survival: 5-year survival rates for localized tumors reach 90.7% to 92.5%.
• Regional survival: Survival for cancer spread to nearby organs is 72.8% to 74.7%.
• Surgical efficacy: Specialized oncology centers report an 85% to 90% surgical efficacy rate.
• Subtype outcomes: Clear cell carcinoma shows approximately 74.9% survival in Korean clinical reports.

Bookimed Expert Insight: Samsung Medical Center and Asan Medical Center handle massive patient volumes, often exceeding 2 million yearly. This high frequency directly correlates with the 90% surgical success rates observed. Specialized centers like Korea University Anam Hospital even offer bloodless surgery protocols. These protocols help patients with personal or medical restrictions avoid transfusions during complex staging.

Patient Consensus: Patients emphasize the importance of getting second pathology reviews from multiple Seoul hospitals before surgery. Finding a surgeon experienced in cytoreductive techniques is often more important than the clinic brand itself.

Hospital stays for ovarian cancer surgery in South Korea typically range from 3 to 10 days. Minimally invasive robotic or laparoscopic procedures often allow discharge within 3 to 7 days. Complex cytoreductive surgeries for advanced cases may require 9 to 17 days of inpatient monitoring.

• Robotic surgery stay: Patients usually remain in the hospital for 6 to 7 days.
• Laparoscopic surgery stay: Hospitalization typically lasts between 3 and 4 days for many patients.
• Initial recovery: Light daily activities can generally be resumed within 4 to 6 weeks.
• Full recovery: Most patients return to all normal activities by 8 to 12 weeks.

Bookimed Expert Insight: Data from major hubs like Severance Hospital and Samsung Medical Center shows a trend toward ultra-fast mobilization. While standard debulking can take 10 days, top surgeons like Dr. Kim Young Tae utilize robotic systems to target 3-day stays. This efficiency allows international patients to transition to outpatient care faster than in many European centers.

Patient Consensus: Patients note that walking on the first day after surgery is highly encouraged to speed up discharge. Many suggest having translation apps ready to navigate the efficient, fast-paced hospital environment during their stay.

South Korea reports a 65.9% overall 5-year survival rate for ovarian cancer. Centres like Samsung Medical Center and Asan Medical Center achieve surgical success rates between 85% and 90%. Early detection yields the best outcomes. Localised cases reach a 92.5% survival rate.

• Surgical efficacy: Leading Seoul hospitals report 85% to 90% success in debulking procedures.
• Localised survival: Statistics Korea data shows up to 92.5% 5-year survival for Stage 1.
• Robotic precision: Korea University Anam Hospital uses bloodless techniques to speed up recovery times.
• Specialised technology: Severance Hospital provides robotic surgery for gynaecologic cancers under JCI-accredited standards.

Bookimed Expert Insight: While survival rates are high, Samsung Medical Center manages over 2,000,000 patients annually. This volume means oncogynaecologists like Dr Kim Byoung Gie handle complex cases frequently. High case volumes often correlate with better outcomes in debulking surgeries.

Patient Consensus: Patients note that success depends on achieving complete debulking. They suggest finding a team with a certified oncogynaecologist. They also recommend requesting a clear care plan for chemotherapy and recurrence monitoring in South Korea.

South Korean tertiary hospitals like Samsung Medical Center and Asan Medical Center lead ovarian cancer care. These JCI-accredited hubs offer Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and robotic-assisted surgeries. They specialise in multidisciplinary oncology. Teams of gynaecologists and oncologists coordinate complex diagnosis and surgery.

• Samsung Medical Center: Provides HIPEC treatment and handles over 2 million annual patient visits.
• Asan Medical Center: Operates the largest medical site in Korea, performing 65,000+ yearly operations.
• Ewha Womans University: Specialises in women's health with a focus on minimally invasive scarring techniques.
• Severance Hospital: Features JCI accreditation and specialises in robotic surgery for comprehensive oncological care.

Bookimed Expert Insight: While many centres treat cancer, Korea University Anam Hospital stands out for pioneering robotic surgical methods. This focus on precision is crucial for ovarian cases. Surgeons there have developed globally recognised techniques. Choosing a robotic-heavy centre can reduce hospital stays compared to traditional open surgery.

Patient Consensus: Patients note it is important to choose Seoul-based hospitals with dedicated gynaecologic units. Integrated imaging is also helpful. Having pathology, PET-CT, and chemotherapy under one roof simplifies the treatment journey in Korea.

South Korean surgeons use robotic-assisted surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) to treat ovarian cancer. Leading Seoul centres achieve survival rates of 85–90% for early-stage cases. These facilities specialise in cytoreductive surgery to remove all visible tumours for better long-term outcomes.

• Robotic surgery: Surgeons use the Da Vinci system at Samsung Medical Center for high precision.
• HIPEC treatment: Heated chemotherapy is applied during surgery to target microscopic cancer cells.
• Cytoreductive surgery: Specialists perform extensive debulking to achieve 'no visible tumour' in 44% of cases.
• Carbon ion therapy: Severance Hospital uses heavy ion beams to treat resistant or deep tumours.
• Laparoscopic techniques: Minimally invasive approaches at Ewha Womans University Medical Center reduce scarring.

Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually. This massive volume allows their surgeons to specialise in complex cases. Dr Kim Byoung Gie leads a department combining surgical skills with targeted therapies.

Patient Consensus: Patients searching for care in Korea often focus on surgeon experience and hospital volume. They highlight the importance of comparing recovery times and follow-up plans before travel to Seoul.

South Korean clinics provide fertility-sparing surgery for early-stage ovarian cancer patients. Specialists perform unilateral salpingo-oophorectomy to remove the affected ovary. This preserves the uterus and healthy ovary. Leading Seoul centres use Da Vinci robotic systems and laparoscopy to maintain reproductive potential safely.

• Patient eligibility: Options typically apply to Stage IA or IC cases and borderline tumours.
• Surgical precision: Surgeons like Dr Kim Young Tae specialise in robotic fertility-sparing procedures.
• Clinical expertise: Samsung Medical Center and Severance Hospital hold JCI and Newsweek recognitions.
• Specialised staging: Specialists perform comprehensive staging to remove cancer while sparing organs.

Bookimed Expert Insight: South Korea's high surgical volume creates unique expertise in robotic oncology. For instance, Korea University Anam Hospital pioneered specific robotic approaches. Asan Medical Center performs over 65,000 operations annually. This experience allows surgeons to offer minimally invasive options for complex fertility preservation.

Patient Consensus: Patients note that eligibility depends strictly on pathology and tumour type. Personal preference is not the deciding factor. Many emphasise discussing egg freezing or embryo preservation with Korean specialists before surgery. This acts as an additional safeguard for future family planning.

Ovarian cancer treatment in South Korea typically requires a stay of 10 to 21 days for surgical cases. Robot-assisted procedures often involve 6 to 7 days in hospital. Laparoscopic surgery generally requires 3 to 4 days. Complex surgeries may extend hospitalisation to 10 days.

• Hospitalisation phase: Surgical stays range from 3 to 10 days depending on the technique.
• Robot-assisted surgery: Robotic systems like Da Vinci require approximately 6 to 7 hospital days.
• Laparoscopic surgery: Minimally invasive ovary removal usually involves a short 3 to 4 day stay.
• Chemotherapy cycles: Inpatient stays for systemic cycles typically last 1 to 3 days per visit.
• Fit-to-fly window: Patients should remain in-country for 7 to 14 days after discharge for safety.

Bookimed Expert Insight: Robotic surgery performed by Dr Kim Young Tae at Severance Hospital offers precise results. Patients should factor in Seoul's high patient volume. Leading centres like Samsung Medical Center treat over 2,000,000 patients annually. This scale ensures surgeons handle complex cases daily, which may shorten recovery through efficient protocols.

Patient Consensus: Patients note that stays vary for diagnosis, surgery, or chemo cycles. Many suggest building in extra days for pathology results or pain management before flying home.